Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients

por Silzle, Tobias, Blum, Sabine, Schuler, Esther, Kaivers, Jennifer, Rudelius, Martina, Hildebrandt, Barbara, Gattermann, Norbert, Haas, Rainer, Germing, Ulrich
Publicado 2019

The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score

por Silzle, Tobias, Blum, Sabine, Kasprzak, Annika, Nachtkamp, Kathrin, Rudelius, Martina, Hildebrandt, Barbara, Götze, Katharina S., Gattermann, Norbert, Lauseker, Michael, Germing, Ulrich
Publicado 2023

Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study

por Koster, Kira-Lee, Messerich, Nora-Medea, Volken, Thomas, Cogliatti, Sergio, Lehmann, Thomas, Graf, Lukas, Holbro, Andreas, Benz, Rudolf, Demmer, Izadora, Jochum, Wolfram, Rao, Tata Nageswara, Silzle, Tobias
Publicado 2023

CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70—A Retrospective Study

por Messerich, Nora-Medea, Uda, Narasimha Rao, Volken, Thomas, Cogliatti, Sergio, Lehmann, Thomas, Holbro, Andreas, Benz, Rudolf, Graf, Lukas, Gupta, Vikas, Jochum, Wolfram, Demmer, Izadora, Rao, Tata Nageswara, Silzle, Tobias
Publicado 2023